Healthtech funding in Q2 2015
European Healthtech startup funding raised during Q2 2015.
In Q2 2015, 49 European Healthtech companies closed 50 funding rounds and raised €301M in equity funding (excluding debt and grants), up 31.1% versus Q2 2014. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.
Equity funding
€301M
+31.1% vs Q2 2014 · excl. debt & grants
Funding rounds
50
+25.0% vs Q2 2014
Companies
49
Top country
UK
Rank among sectors
#6
5.6% of sector funding
Top-10 round share
72.2%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q2 2015 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Apr | €171M | 19 |
| May | €81M | 14 |
| Jun | €56M | 17 |
Top countries
by € raisedHealthtech — top countries by capital, Q2 2015 — interactive chart.
Data table
| Healthtech — top countries by capital, Q2 2015 | |
|---|---|
| UK | €70M |
| Switzerland | €59M |
| France | €54M |
| Israel | €38M |
| Germany | €15M |
| Finland | €14M |
| Sweden | €13M |
| Lithuania | €9.3M |
Stage mix
by € raisedHealthtech — stage mix, Q2 2015 — interactive chart.
Data table
| Healthtech — stage mix, Q2 2015 | |
|---|---|
| Series B | €121M |
| Growth/Late | €67M |
| Series A | €46M |
| Early VC | €28M |
| Seed | €24M |
| Other | €9.6M |
| Grant | €7.4M |
| Series D+ | €4.6M |
Top deals
largest disclosed rounds in Q2 2015| Company | Stage | Date | Amount |
|---|---|---|---|
| CRISPR Therapeutics | Series B | Apr 2015 | €59M |
| Kymab | Series B | May 2015 | €45M |
| Echosens | Growth/Late | Apr 2015 | €31M |
| Advanced Accelerator Applications | Growth/Late | Jun 2015 | €23M |
| Allecra Therapeutics | Series A | Apr 2015 | €15M |
| BONESUPPORT | Growth/Late | Apr 2015 | €13M |
| Onbone | Early VC | Apr 2015 | €10M |
| Vittamed | Other | Apr 2015 | €9.3M |
| docplanner | Series B | May 2015 | €8.9M |
| TalkSpace | Series A | May 2015 | €8.5M |
| Qinec | Series B | Jun 2015 | €8.3M |
| Zebra Medical Vision | Seed | Apr 2015 | €7.3M |
| OrthoSpace | Early VC | May 2015 | €7.1M |
| Zesty | Series A | May 2015 | €6.4M |
| Genome Compiler | Series A | Jun 2015 | €5.8M |
Top investors
most active in Q2 2015, by deal count- High-Tech Gründerfonds (HTGF)2 deals
- OurCrowd2 deals
- SEEDIL2 deals
- Abingworth LLP1 deals
- Abramovich1 deals
- Amadeus Capital Partners1 deals
- Antares Private Equity1 deals
- Atlante Ventures1 deals
- Bayer Global Investments1 deals
- BizTEC1 deals